Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Novel PET radiotracer shows high sensitivity, specificity in diagnosing coronary artery disease in obese patients

A novel PET perfusion radiotracer, 18F-flurpiridaz, can diagnose coronary artery disease (CAD) in obese patients with a higher sensitivity and specificity compared to 99mTc-SPECT myocardial perfusion imaging (MPI), according to research presented at the 2023 Society of Nuclear Medicine and Molecular Imaging Annual Meeting. 18F-flurpiridaz PET MPI obtained images at a lower radiation dose than 99mTc-SPECT MPI and performed similarly in both obese and non-obese patients.

27 Jun 2023

UTHSC team poised to make a real-world impact on vulnerable cancer patients

A University of Tennessee Health Science Center research team is poised to make a real-world impact on vulnerable cancer patients, thanks to new support from the State of Tennessee.

27 Jun 2023

Seven risk factors for early onset colorectal cancer in males identified

Colorectal cancer incidence and deaths are declining for individuals age 50 and older, but are increasing for those under 50.

27 Jun 2023

Study: Cancer patients with unmet supportive care needs more likely to experience worse outcomes

Cancer patients with unmet supportive care needs are more likely to experience worse clinical outcomes, including more emergency department (ED) visits and hospitalizations, according to new research from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine.

26 Jun 2023

New study shows promise for diphenyl ditelluride as anti-cancer drug

A new research paper was published in Oncotarget's Volume 14 on June 21, 2023, entitled, "Diphenyl ditelluride anticancer activity and DNA topoisomerase I poisoning in human colon cancer HCT116 cells."

26 Jun 2023

New kidney cancer model highlights molecular targets and genomic events that drive metastasis

Researchers at The University of Texas MD Anderson Cancer have engineered a new model of aggressive renal cell carcinoma (RCC), highlighting molecular targets and genomic events that trigger chromosomal instability and drive metastatic progression.

26 Jun 2023

Research shows fertility challenges for women treated for childhood Hodgkin lymphoma

Women treated for childhood Hodgkin lymphoma may face declining fertility at a younger age, according to research presented today (Monday) at the 39th annual meeting of the European Society of Human Reproduction and Embryology.

26 Jun 2023

New white paper on challenges and opportunities in theranostics education

Leaders from 12 nuclear medicine organizations around the world have issued a white paper about the challenges and opportunities in theranostics education.

23 Jun 2023

Eliminating cancer cell repopulation may be the key to curing cancer

A new research perspective was published in Oncoscience (Volume 10) on June 1, 2023, entitled, "Cancer cell repopulation after therapy: which is the mechanism?"

23 Jun 2023

New study offers hope for women suffering from axillary web syndrome

Axillary web syndrome, also known as lymphatic thrombus, is a complication in the clinical manifestations suffered by many women after overcoming breast cancer, mainly affecting their shoulder mobility.

23 Jun 2023

New standard more effective at preventing graft-versus-host disease

Clinicians have a new standard for graft-versus-host disease (GVHD) prevention after allogeneic hematopoietic stem cell transplantation, according to results from a phase III study published June 22 in the New England Journal of Medicine.

22 Jun 2023

Study finds new way to predict therapy response in metastatic renal cell carcinoma

Dr. Niklas Klümper, resident at the Department of Urology and Pediatric Urology of the University Hospital Bonn (UKB) and working group leader at the Institute for Experimental Oncology (IEO), and Dr. Jonas Saal, resident at the Medical Clinic III for Oncology, Hematology, Immune-Oncology and Rheumatology of the UKB, demonstrated a significant improvement in predicting the response to therapy in metastatic renal cell carcinoma by incorporating the level of inflammation, which was assessed using two straightforward blood parameters, alongside the conventional imaging-based approach.

22 Jun 2023

MD Anderson and Ochsner Health join forces to advance cancer care in Louisiana

The University of Texas MD Anderson Cancer Center and New Orleans-based Ochsner Health today announced a partnership to create Ochsner MD Anderson Cancer Center in southeastern Louisiana.

22 Jun 2023

First successful Phase 2 trial uses cutting-edge RNA CAR-T therapy to treat autoimmunity

Cartesian Therapeutics, a clinical-stage biotechnology company pioneering cell therapies for autoimmune diseases, announced today the publication of a landmark paper in The Lancet Neurology.

22 Jun 2023

Study investigates whether metformin mitigates androgen deprivation therapy-related metabolic syndrome

A new research paper was published in Oncotarget's Volume 14 on June 19, 2023, entitled, "Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer."

21 Jun 2023

New measurement tool helps analyze quality of life after childhood cancer

A new measurement tool helps analyze the survival rate of children with cancer, but also the quality of survival.

20 Jun 2023

Radiation combined with cancer-targeting virus therapy more effective in fighting brain tumors

Combining a cancer-targeting virus with radiation to treat brain cancer in mice was more effective than either therapy on its own according to University of Alberta research, providing hope for new treatments that combine immunotherapy with traditional surgery, chemotherapy or radiation.

20 Jun 2023

INTEGRA Biosciences’ pipettes help to advance cancer drug discovery

The Institute for Cancer Research (ICR), part of the University of London, is using VIAFLO electronic pipettes from INTEGRA Biosciences to streamline its preclinical drug screening and translational medicine workflows.

From INTEGRA Biosciences 20 Jun 2023

Phase I clinical study of TCR NK cell therapy for sarcoma expected to commence later this year

The University of Texas MD Anderson Cancer Center and Replay today announced that the Food & Drug Administration (FDA) has issued a 'safe to proceed' for the Investigational New Drug (IND) application for NY-ESO-1 TCR/IL-15 NK, an engineered T cell receptor natural killer (TCR NK) cell therapy for advanced synovial sarcoma and myxoid/round cell liposarcoma.

20 Jun 2023

Researchers develop a prediction tool for blood cancer therapies

Since its introduction in 2015, a prediction tool developed by the European Society of Medical Oncology has been providing support worldwide in the assessment of the clinical benefits of new cancer therapies.

20 Jun 2023

Oncology News and Research

Further Reading

Novel PET radiotracer shows high sensitivity, specificity in diagnosing coronary artery disease in obese patients

UTHSC team poised to make a real-world impact on vulnerable cancer patients

Seven risk factors for early onset colorectal cancer in males identified

Study: Cancer patients with unmet supportive care needs more likely to experience worse outcomes

New study shows promise for diphenyl ditelluride as anti-cancer drug

New kidney cancer model highlights molecular targets and genomic events that drive metastasis

Research shows fertility challenges for women treated for childhood Hodgkin lymphoma

New white paper on challenges and opportunities in theranostics education

Eliminating cancer cell repopulation may be the key to curing cancer

New study offers hope for women suffering from axillary web syndrome

New standard more effective at preventing graft-versus-host disease

Study finds new way to predict therapy response in metastatic renal cell carcinoma

MD Anderson and Ochsner Health join forces to advance cancer care in Louisiana

First successful Phase 2 trial uses cutting-edge RNA CAR-T therapy to treat autoimmunity

Study investigates whether metformin mitigates androgen deprivation therapy-related metabolic syndrome

New measurement tool helps analyze quality of life after childhood cancer

Radiation combined with cancer-targeting virus therapy more effective in fighting brain tumors

INTEGRA Biosciences’ pipettes help to advance cancer drug discovery

Phase I clinical study of TCR NK cell therapy for sarcoma expected to commence later this year

Researchers develop a prediction tool for blood cancer therapies

eBook: Liquid biopsy in cancer research eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News